The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.


Updates from The Motley Fool

Latest updates on Vertex Pharmaceuticals from Fool.com.  The Fool has written over 300 articles on Vertex Pharmaceuticals.
Last Week's Best Healthcare ETF

Healthcare focused ETFs soared this past week, and this one fund in particular put up a market-th...



Stock Performance

View Interactive VRTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Vertex Pharmaceuticals.
Current Price: $86.07
Prev Close: $85.73
Open: $85.73
Bid: $84.50
Ask: $89.50
Day's Range: $84.62 - $86.11
52wk Range: $71.46 - $103.73
Volume: 1,406,787
Avg Vol 1,609,692
Market Cap: $21B
P/E (ttm): -186.37
EPS (ttm): $0.85
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Vertex Pharmaceuticals.
CAPS Rating 4 out of 5
 
726 Outperform
65 Underperform
CAPS All Stars
 
195 Outperform
11 Underperform

How do you think Vertex Pharmaceuticals will perform against the market?



You pick for Vertex Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jeffrey Leiden, M.D., Ph.D, CEO

70% Approve

Based on 75 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Vertex Pharmaceuticals.

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers